May 3, 2021
Gene Therapy for Sickle Cell Did Not Cause Patient's Leukemia
There is no evidence that a promising gene therapy for sickle cell disease triggered leukemia in a patient, according to the company testing the experimental treatment. Bluebird Bio announced a few weeks ago that a sickle cell patient treated with the gene therapy five years ago in a clinical trial had developed acute myeloid leukemia...
Parkinson's Drug Eyed as Treatment for Severe Macular Degeneration
A drug long used to treat Parkinson’s disease may benefit patients with a severe form of age-related macular degeneration (AMD), a small clinical trial suggests. One of the leading causes of vision loss in older people is a condition called dry macular degeneration. More than 15% of Americans over age 70 have AMD, and 10%...